Ken Fisher acquired 15 Million GSK Plc - ADR shares worth $646 Million. That's 0.32% of their equity portfolio (83rd largest holding). The first GSK Plc - ADR trade was made in Q1 2013. Since then Ken Fisher bought shares 33 more times and sold shares on ten occasions. The stake costed the investor $636 Million, netting the investor a gain of 1.6% so far.
Emulating the moves of hedge fund stock pickers, and some of the most successful hedge funds can produce sizable profits for retail investors. In fact, here ...
InvestorPlace, 7 months agoMajor players in the pharmacogenomics market are Abbott Laboratories, AstraZeneca plc, Becton Dickinson and Company, Bayer AG, F Hoffmann-La Roche AG, Illumi...
GlobeNewswire, over 1 year ago